Diefenbach, C, Kahl, BS, McMillan, A, Briones, J, Banerjee, L, Cordoba, R, Miall, F, Burke, JM, Hirata, J, Jiang, YW, Paulson, JN, Chang, YM, Musick, L, Abrisqueta, P. Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study. Lancet Haematology. 2021; 8(12)DOI:10.1016/S2352-3026(21)00311-2. PMID:34826412. IF:30.153(Q1/1D).

Albiol, N, Arguello-Tomas, M, Moreno, C. The road to chemotherapy-free treatment in chronic lymphocytic leukaemia. CURRENT OPINION IN ONCOLOGY. 2021; 33(6)DOI:10.1097/CCO.0000000000000791. PMID:34474439. IF:3.915(Q3/6D).

Moreno, C, Munoz, C, Terol, MJ, Hernandez-Rivas, JA, Villanueva, M. Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2021; 40(1)DOI:10.1186/s13046-021-02115-1. PMID:34654437. IF:12.658(Q1/1D).

Einsele, H, Briones, J, Ciceri, F, Cadenas, IG, Falkenburg, F, Bolanos, N, Heemskerk, HMM, Houot, R, Hudecek, M, Locatelli, F, Morgan, K, Morris, EC, O'Dwyer, M, Sierra, JG, van den Brink, M, van de Loosdrecht, AA. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. Hemasphere. 2021; 5(10)DOI:10.1097/HS9.0000000000000642. PMID:34522844. IF:8.300(Q1/2D).

Genesca, E, Morgades, M, Gonzalez-Gil, C, Fuster-Tormo, F, Haferlach, C, Meggendorfer, M, Montesinos, P, Barba, P, Gil, C, Coll, R, Moreno, MJ, Martinez-Carballeira, D, Garcia-Cadenas, I, Vives, S, Ribera, J, Gonzalez-Campos, J, Diaz-Beya, M, Mercadal, S, Artola, MT, Cladera, A, Tormo, M, Bermudez, A, Vall-llovera, F, Martinez-Sanchez, P, Amigo, ML, Monsalvo, S, Novo, A, Cervera, M, Garcia-Guinon, A, Ciudad, J, Cervera, J, Hernandez-Rivas, JM, Granada, I, Haferlach, T, Orfao, A, Sole, F, Ribera, JM. Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL). LEUKEMIA RESEARCH. 2021; 109DOI:10.1016/j.leukres.2021.106612. PMID:34139642. IF:3.715(Q3/6D).

Ribera, JM, Morgades, M, Coll, R, Barba, P, Lopez-Lorenzo, JL, Montesinos, P, Foncillas, MA, Cabrero, M, Gomez-Centurion, I, Morales, MD, Varela, MR, Herrera, P, Garcia-Cadenas, I, Calbacho, M, Torrent, A, Maluquer, C, Calabuig, M, Garcia-Guinon, A, Bautista, G, Llorente, L, Gil, C, Artola, MT, Gonzalez-Campos, J, Fernandez-Moreno, A, Barez, A, Gimenez-Perez, T, Bergua, J, Sanchez-Sanchez, MJ, Mateos, MC, Pinana, JL. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain. Clinical Lymphoma Myeloma & Leukemia. 2021; 21(10)DOI:10.1016/j.clml.2021.06.024. PMID:34376375. IF:2.822(Q3/8D).

Ribera, JM, Morgades, M, Genesca, E, Chapchap, EC, Montesinos, P, Acuna-Cruz, E, Gil, C, Garcia-Cadenas, I, Barba, P, Gonzalez-Campos, J, de Llano, MPQ, Torrent, A, Ribera, J, Granada, I, Bernal, T, Diaz-Beya, M, Amigo, ML, Coll, R, Tormo, M, Vall-llovera, F, Gomez-Centurion, I, Sanchez-Sanchez, MJ, Soria, B, Cladera, A, Artola, MT, Garcia-Guinon, A, Gimenez-Conca, A, Amador, ML, Martinez-Sanchez, P, Algarra, JL, Vidal, MJ, Alonso, N, Maluquer, C, Llorente, L, Garcia-Boyero, R, Ciudad, J, Feliu, E, Orfao, A. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials. HEMATOLOGICAL ONCOLOGY. 2021; 39(4)DOI:10.1002/hon.2910. PMID:34405901. IF:4.850(Q2/5D).

Ljungman, P, de la Camara, R, Mikulska, M, Tridello, G, Aguado, B, Al Zahrani, M, Apperley, J, Berceanu, A, Bofarull, RM, Calbacho, M, Ciceri, F, Lopez-Corral, L, Crippa, C, Fox, ML, Grassi, A, Jimenez, MJ, Demir, SK, Kwon, M, Llamas, CV, Lorenzo, JLL, Mielke, S, Orchard, K, Porras, RP, Vallisa, D, Xhaard, A, Knelange, NS, Cedillo, A, Kroger, N, Pinana, JL, Styczynski, J. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. LEUKEMIA. 2021; 35(10)DOI:10.1038/s41375-021-01302-5. PMID:34079042. IF:12.897(Q1/1D).